SLNs were prepared by a fusion-emulsification method as described elsewhere [6]. In short, 300 mg of lipid (Compritol® 888 ATO) and different amounts of etofenamate or ibuprofen were taken in a 50 mL beaker (oil or lipid phase). The aqueous phase consisted of 10 mL of 2% (w/w) Tween®80 aqueous solution. Both the aqueous phase and the lipid phase were placed in a water bath (Water Bath VWR 6, VWR, Darmstadt, Germany) at 80–90 °C. After the fusion of the lipids, the aqueous phase was added under high stirring (Silverson SL5M, Silverson LDT Machines, Chesham, UK) at a speed of 12,500 rpm for 10 min. The preparation was removed from the bath, cooled in ice for solidification. Nanoparticles were stored at 4 °C until further use.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.